Your browser doesn't support javascript.
loading
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.
Abbate, Antonio; Trankle, Cory R; Buckley, Leo F; Lipinski, Michael J; Appleton, Darryn; Kadariya, Dinesh; Canada, Justin M; Carbone, Salvatore; Roberts, Charlotte S; Abouzaki, Nayef; Melchior, Ryan; Christopher, Sanah; Turlington, Jeremy; Mueller, George; Garnett, James; Thomas, Christopher; Markley, Roshanak; Wohlford, George F; Puckett, Laura; Medina de Chazal, Horacio; Chiabrando, Juan G; Bressi, Edoardo; Del Buono, Marco Giuseppe; Schatz, Aaron; Vo, Chau; Dixon, Dave L; Biondi-Zoccai, Giuseppe G; Kontos, Michael C; Van Tassell, Benjamin W.
Affiliation
  • Abbate A; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Trankle CR; "Kenneth and Dianne Wright" Center for Clinical and Translational Research MedStar Washington Hospital Center Washington DC.
  • Buckley LF; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Lipinski MJ; Department of Pharmacotherapy and Outcomes Science MedStar Washington Hospital Center Washington DC.
  • Appleton D; Medstar Heart and Vascular Institute MedStar Washington Hospital Center Washington DC.
  • Kadariya D; Virginia Cardiovascular Specialists Richmond VA.
  • Canada JM; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Carbone S; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Roberts CS; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Abouzaki N; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Melchior R; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Christopher S; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Turlington J; Virginia Cardiovascular Specialists Richmond VA.
  • Mueller G; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Garnett J; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Thomas C; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Markley R; Virginia Cardiovascular Specialists Richmond VA.
  • Wohlford GF; Virginia Cardiovascular Specialists Richmond VA.
  • Puckett L; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Medina de Chazal H; Virginia Cardiovascular Specialists Richmond VA.
  • Chiabrando JG; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Bressi E; Department of Pharmacotherapy and Outcomes Science MedStar Washington Hospital Center Washington DC.
  • Del Buono MG; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Schatz A; Virginia Cardiovascular Specialists Richmond VA.
  • Vo C; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Dixon DL; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Biondi-Zoccai GG; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Kontos MC; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
  • Van Tassell BW; Virginia Commonwealth University Pauley Heart Center MedStar Washington Hospital Center Washington DC.
J Am Heart Assoc ; 9(5): e014941, 2020 03 03.
Article in En | MEDLINE | ID: mdl-32122219

Full text: 1 Database: MEDLINE Main subject: Systemic Inflammatory Response Syndrome / Antirheumatic Agents / Interleukin 1 Receptor Antagonist Protein / ST Elevation Myocardial Infarction / Heart Failure Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Systemic Inflammatory Response Syndrome / Antirheumatic Agents / Interleukin 1 Receptor Antagonist Protein / ST Elevation Myocardial Infarction / Heart Failure Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article